Sinopharm Group To Help Shenzhen City Government Set Up Biomedical R&D Center
This article was originally published in PharmAsia News
Executive Summary
Accord Pharmaceutical recently announced that its controlling shareholder, Sinopharm Group, signed an agreement with the Shenzhen city government